Download presentation
Presentation is loading. Please wait.
Published byValentina Monhollen Modified over 9 years ago
1
Duong et al Figure 1 A InputsGST-Mdm2 HEGO HE11HE19HE15 HEGO HE11 HE19HE15 B HEGO A/BCEFD 1595 HE11 A/BEFD CEFD HE19 A/BC HE15 C D ER I GST-Mdm2GST C E2 OHT Luciferase activity Mdm2 ER 64 - 98 - Input IP:Mdm2 1 2 3 4 Input IP:Mdm2 0 2000 * 1000 3000 Gal4 Gal-mdm2 + VP16 Gal-mdm2 + ER-VP16 Galmdm2 + VP16+ p53 Gal-mdm2 + ER-VP16+ p53 Gal-GRIP + VP16 Gal-GRIP + ER-VP16 I GST-LBD C E2 Mdm2 GST ER p53 Mdm2 5 6 7 Input IP:ER IP: IgG
2
Duong et al Figure 2 ER C E2 A Actin MEFWTMEFdKO B C ER C E2 Controlp53+Mdm2 Mdm2 - + ++ D ER Actin Mdm2 MG132 - + - - + + Actin ER 0 2 4 ER Mdm2 w/o Estradiol CHX treatment (hrs) ER + Mdm2 Actin Mdm2 overexpression - +
3
C A C E2 GST GST-AF2 Input Mdm2 Mdm2 RING Duong et al Figure 3 ER (HE11) Actin Mdm2 4 5 6 ER ER + Mdm2 WT ER ER + Mdm2 RING Mdm2 WT Mdm2 RING Actin C E2 Mdm2 ER Actin Mdm2 1 2 3 D Mdm2 - + ER -Ub ER IP: ER IB: Ub IB: ER 170 - 130 - 95 - 72 - 55 - 43 - ER -Ub B
4
Duong et al Figure 4 C C E2 OHT ICI ControlUV C E2 OHT ICI ER p53 Actin D A 0 1 2 3 4 CMG UV ActD Apoptosis (AU) MG132 C E1 E2 E3 DES Control ER Actin B C E1 E2 E3 DES p53 ER Actin p53 C E2 ControlMG UVActD ER p53 Actin
5
A 10 100 024 6 E2 E2+UV Hours of chase ER levels (% of control) Duong et al Figure 5 C - + - + - + RITA Control 2h4h8h ER p53 Actin B E2 +UV 0 2 4 6 E2 CHX treatment (hrs) ER p53 ER p53
6
Relative luciferase activity CE2 C p53+Mdm2 MEFdKO 0 200 400 600 800 1000 1200 B 0 100 200 300 400 500 CUV Control E2 A 0 100 200 300 400 500 600 700 800 900 CE2OHTICI MCF7BG1 CE2OHTICI D Duong et al Figure 6 Control Relative luciferase activity C E2 BG1 cells ER Actin C E2 Control pS2 p53 actin C E2 UV C
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.